CIK 0001613780 · Non-accelerated filer<br>Smaller reporting company
DBV Technologies S.A.
Sign in to watch- Ticker
- DBVTF
- Exchange
- Nasdaq, OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- France
- Entity type
- operating
- Phone
- 330155427878
- Business address
- 107 AVENUE DE LA REPUBLIQUE, CHATILLON, France
Securities
- DBVT American Depositary Shares Nasdaq
- DBVTF Common stock OTC
- 8-K Event Other events
- F-6EF Other F-6EF
- 8-K Event Shareholder vote results
- 8-K Event Other events
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- PRER14A Other PRER14A
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Regulation FD disclosure
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Medical Officer acquired 8,700 shares (grant or award)
Page 11 of 29 · 577 filings